We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-6.4%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$88M
AUM Growth
-$19.7M
Cap. Flow
-$5.9M
Cap. Flow %
-6.7%
Top 10 Hldgs %
91.84%
Holding
33
New
7
Increased
14
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$2.62M
2
AMLP icon
Alerian MLP ETF
AMLP
+$473K
3
ABDC
Alcentra Capital Corp
ABDC
+$320K
4
V icon
Visa
V
+$224K
5
MA icon
Mastercard
MA
+$223K

Top Sells

Rank Stock Value
1
ICMB icon
Investcorp Credit Management BDC
ICMB
+$6.32M
2
LITS
Lite Strategy Inc
LITS
+$3.98M
3
ARQL
Arqule Inc
ARQL
+$700K
4
MRKR icon
Marker Therapeutics
MRKR
+$110K
5
GSM icon
FerroAtlántica
GSM
+$15.2K

Sector Composition

Rank Sector Weight
1 Healthcare 66.39%
2 Financials 3.8%
3 Consumer Discretionary 0.56%
4 Industrials 0.52%
5 Technology 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSM icon
26
FerroAtlántica
GSM
$626M
$223K 0.25%
131,248
-7,978
-6% -$15.2K
EXPE icon
27
Expedia Group
EXPE
$32.3B
$216K 0.25%
+1,622
New +$200K
MCO icon
28
Moody's
MCO
$89.2B
$214K 0.24%
+1,094
New +$208K
IBKR icon
29
Interactive Brokers
IBKR
$40.3B
$201K 0.23%
+14,812
New +$201K
MRKR icon
30
Marker Therapeutics
MRKR
$21.8M
$189K 0.21%
2,392
-1,845
-44% -$110K
FSTX
31
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$88K 0.1%
5,955
+26
+0.4% +$696
ICMB icon
32
Investcorp Credit Management BDC
ICMB
$12.3M
– –
-862,670
Closed -$6.32M
ARQL
33
DELISTED
Arqule Inc
ARQL
– –
-146,066
Closed -$700K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q2 2019 Portfolio in Review

As of Q2 2019, Caxton Corporation held 33 positions worth $88M, down 18% from $108M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Caxton Corporation withdrew a net $5.9M in Q2 2019, closing 2 positions and reducing 5 holdings. Its most notable exit was Investcorp Credit Management BDC, an estimated $6.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 69% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Caxton Corporation opened a new position in Visa worth $238K.

  • Caxton Corporation's largest Q2 2019 buy was Visa: 1,370 shares worth $238K.
  • Caxton Corporation added most to Viracta Therapeutics, Inc. Common Stock in Q2 2019, an estimated $2.62M increase.
  • Caxton Corporation's biggest Q2 2019 reduction was Lite Strategy Inc, cutting an estimated $3.98M.
  • Caxton Corporation fully exited Investcorp Credit Management BDC in Q2 2019, selling an estimated $6.32M.
  • Caxton Corporation's ten largest holdings make up 92% of its $88M portfolio in Q2 2019.
  • Caxton Corporation opened 7 new positions and closed 2 in Q2 2019.
  • Caxton Corporation's portfolio value fell 18% quarter-over-quarter to $88M.

Based on Caxton Corporation's 13F filing for Q2 2019, filed 14 Aug 2019.